Age-related Macular Degeneration (AMD) is a leading cause of vision loss in people over age 50 and can result in Low Vision. In the United States alone, the number of people with advanced AMD, is quickly approaching 3 million, and is expected to increase to 5.4 million by 2050. There is currently no cure for AMD, making it a major public health crisis. As with many kinds of vision loss, especially those involving the central visual field, it is easy to think of the disorder as a loss of acuity – reading becomes difficult, small objects are hard to distinguish, and faces can be a blur. However, for people with Low Vision due to retinal damage, regular treatments - such as glasses or medicine - no longer aid in improving vision, thus making everyday activities, such as reading and navigating, difficult.
This month we join the Vision community in educating the public about AMD/Low Vision in the hope of informing individuals about possible causes, functional changes, and assistive technologies that can help people with Low Vision live independent lives.
Research aimed at alleviating the limitations experienced with low vision is essential and is a major component of the work at Smith-Kettlewell. We invite you to learn about the important work being done here.